HempFusion, Inc. Raises $36 Million in Up-Sized Financing Round

HempFusion, Inc. operates as a U.S.-based premium CBD company, which has a footprint of 30 products in over 3,400 retailers across 47 states. The CBD wellness brand uses only high-quality organic industrial hemp for extraction, processing, and manufacturing under strict cGMP protocols. HempFusion’s product line is based around its proprietary “Whole Food Hemp Complex” technology. Among HempFusion’s diverse product line,…

Read More

Surna, Inc. (OTCQB: SRNA) Surges 79% After Reporting Second Quarter 2019 Earnings Showing First Profitable Quarter Ever

Surna, Inc. (OTCQB: SRNA) is engaged within the design, engineering, and manufacture of controlled environment and air sanitation systems for regulated indoor cannabis cultivation. The company’s cultivation solutions help with temperature precision, humidity control, and other process controls to ensure highest quality, while maintaining compliance with state, provincial, and local laws. Since 2006, Surna has been involved within the consultation,…

Read More

Henry’s Original Hauls $11 Million Series B Led By Merida Capital Partners

Henry’s Original operates as a California-based vertically-integrated cannabis company, which cultivates its flower products entirely out of Mendocino County. The cannabis company holds a combined thirteen licenses with the state of California, which cover nursery, cultivation, processing, distribution, and sales. Overall, Henry’s Original holds over 100,000 square feet of cannabis cultivation space and a retail dispensary license in California. Among…

Read More

Aphria, Inc. (NYSE: APHA) (TSX: APHA) Climbs 33% After Reporting Fiscal Fourth Quarter Results Showing Strong Sales Growth, Profitability

Aphria, Inc. (NYSE: APHA) (TSX: APHA) is a Canadian cannabis company based out of Leamington, Ontario. The Canadian cannabis company focuses on producing high-quality flower at scale, which helps lower costs and improve profitability. Aphria’s global reach spans over ten countries across five continents. U.S.-listed shares of Aphria are jumping 33.46%, through early trading on Friday, August 2, 2019. Over…

Read More

View Systems, Inc. (OTC Pink: VSYM) Climbs 24% After Closing Acquisition of Colombia Medical Marijuana and Hemp Company, Sannabis

View Systems, Inc. (OTC Pink: VSYM) operates as a technology and cannabis company. The company’s ViewScan Weapons Detection System is a Department of Homeland Security approved product for use in a wide range of locations: courthouse, law enforcement/corrections facilities, schools, sports venues, military facilities, commercial businesses, and more. Shares of the technology and cannabis company is rallying 24%, through early…

Read More

Fire & Flower Holdings Corp. (TSXV: FAF) Rallies 11.40% After Receiving Strategic Investment From Alimentation Couche-Tard, Inc. (TSX: ATD.B)

Fire & Flower Holdings Corp. (TSXV: FAF) operates as an independent recreational cannabis retailer primarily operating in Canada. The cannabis retailer seeks to provide services and education to its customers, in an effort to connect individuals with information to improve their experience. Fire & Flower’s Hifyre digital platform helps customers seamlessly search through cannabis products. The company’s licensed retail subsidiary,…

Read More

Bombshell: Emails Show CannTrust Holdings, Inc. (NYSE: CTST) (TSX: TRST) Chairman and CEO Knew of Unlicensed Cannabis Cultivation Back in November 2018

The CannTrust Holdings, Inc. (NYSE: CTST) (TSX: TRST) scandal just took a sinister turn for worst. According to Canada’s Globe and Mail, internal emails at CannTrust show that chairman Eric Paul and CEO Peter Aceto were made aware of cannabis cultivation taking place in unlicensed rooms at its facility in Southern Ontario. To make matters even worse, the emails allegedly…

Read More

Therapix Bioscience, Ltd. (NASDAQ: TRPX) Jumps 40% After LOI to Merge with Destiny Biosciences Global Corp.

Therapix Bioscience, Ltd. (NASDAQ: TRPX) operates as a clinical-stage pharmaceutical company, which is focused on developing a pipeline and assets based on cannabinoid-based pharmaceutical treatments. The Israeli cannabis pharma developer currently has tetrahydrocannabinol- (THC) and CannAmide-based drug development programs. Shares of the cannabinoid pharmaceutical developer are jumping 40%, through afternoon trading on Tuesday, July 23, 2019. Over the past three…

Read More

Cannabis Biotech Startup, Demetrix Raises $50 Million Series A

Demetrix is engaged as an Emeryville, CA-based biotechnology startup that is focused on the production of cannabinoids. Utilizing microorganisms like baker’s yeast and fermentation, along with advanced biotechnology procedures, Demetrix is able to produce complex ingredients at a very high purity without the excessive costs. The goal is to develop high-quality cannabinoids for the use in pharmaceuticals, supplements, consumer products,…

Read More

Breaking Down the UK Cannabis Market

Among world superpowers, the Canada has definitely led the way in the legalization and decriminalization of cannabis. The United States has certainly made strong strides over the past year as well. Many are expecting the UK to follow suit, but it’s been a slow burn. The UK has been making strides with their legalization of medical cannabis last year, and…

Read More